Tevogen Bio Holdings Inc.
TVGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $151,073 | $1,839,482 | $1,239,600 | $476,457 |
| - Cash | $1,283 | $9 | $129 | $7,119 |
| + Debt | $2,886 | $1,632 | $40,008 | $23,479 |
| Enterprise Value | $152,676 | $1,841,105 | $1,279,479 | $492,817 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$404 | -$378 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$13,140 | -$58,893 | $4,408 | -$14,989 |
| % Margin | – | – | – | – |
| Net Income | -$10,114 | -$60,478 | $4,408 | -$15,597 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.094 | -0 | 0.037 | -0.33 |
| % Growth | -23,300% | -101.1% | 111.1% | – |
| Operating Cash Flow | -$11,999 | -$8,171 | -$8,656 | -$5,275 |
| Capital Expenditures | $0 | -$133 | -$479 | -$110 |
| Free Cash Flow | -$11,999 | -$8,304 | -$9,135 | -$5,385 |